ANCIX
Price
$16.92
Change
-$0.60 (-3.42%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

ANCIX vs VSIAX

Header iconANCIX vs VSIAX Comparison
Open Charts ANCIX vs VSIAXBanner chart's image
Ancora MicroCap I
Price$16.92
Change-$0.60 (-3.42%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
ANCIX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ANCIX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANCIX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. ANCIX (19.6M). VSIAX pays higher dividends than ANCIX: VSIAX (2.01) vs ANCIX (1.20). ANCIX was incepted earlier than VSIAX: ANCIX (16 years) vs VSIAX (13 years). ANCIX is a more actively managed with annual turnover of: 42.13 vs. VSIAX (16.00). VSIAX has a lower initial minimum investment than ANCIX: VSIAX (3000) vs ANCIX (5000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. ANCIX (5.73). ANCIX return over 5 years is better than : 69.13 vs. VSIAX (52.83).
ANCIXVSIAXANCIX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years13 years-
Gain YTD5.98915.03140%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets19.6M63B0%
Annual Yield % from dividends1.202.0160%
Returns for 1 year5.7316.2335%
Returns for 3 years22.8720.67111%
Returns for 5 years69.1352.83131%
Returns for 10 years13.47105.6513%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics